Immune response to SARS-CoV-2 mRNA vaccine in patients with psoriasis treated with biologics.

Maruška MarovtPetra DeželakRobert EkartPij B Marko

Published in: Clinical and experimental dermatology (2022)

The effect of psoriasis treatment with biologics on the efficacy of COVID-19 vaccines is largely unknown. Our study aimed to evaluate antibody response against SARS-CoV-2 following two doses of BNT162b2 (Pfizer/BioNTech vaccine) in patients with psoriasis receiving biologic monotherapy, and compare it with that of healthy controls.

Keyphrases

sars cov
immune response
respiratory syndrome coronavirus
combination therapy
rheumatoid arthritis
atopic dermatitis
coronavirus disease
randomized controlled trial
clinical trial
dendritic cells
open label
toll like receptor
smoking cessation